Title: Strategies for Successful Oncology Recurrence Trials
Date: Wednesday, April 6, 2022
Time: 11:45 AM PT
This presentation will address successful strategies for oncology recurrence trials including review of operational and read recommendations to help you improve efficiency and quality for your recurrence studies.
VP, Medical and Scientific Affairs, Medical Imaging at Clario
Dr. Zaim is a recognized medical imaging expert in clinical trials with more than 25 years of medical, scientific and industry experience and was most recently chief medical officer at Median Technologies. He is responsible for ensuring the strategic and long-term medical, scientific and technical development of Clario’s Medical and Science Affairs organization in concert with the Medical Imaging Chief Medical Officer, Dr. Michael O’Neal, and Chief Science Officer, Dr. Thomas Fuerst.
Dr. Zaim was previously with Synarc (merged with Bioclinica, now Clario) for more than a decade in various leadership roles, director of radiology services for Europe, medical director, and vice president of radiology. In these roles, Dr. Zaim established and developed global medical and science affairs teams supporting an array of clinical trial indications. Dr. Zaim is regularly published in peer-reviewed journals, and has extensive central reading and adjudication experience encompassing thousands of patients in hundreds of clinical trials in Oncology, Arthritis, Osteoporosis and other areas.
Prior to this, he was assistant professor of Radiology at the University of California at San Francisco. He earned a medical degree from the University of Algiers, Algeria and is board certified in Radiology with a certificate in Magnetic Resonance, both from the University of Paris. Dr. Zaim is a member of the Radiological Society of North America, the European Society of Radiology, and the American Society of Clinical Oncology.